Syamal Roy Selected Research

Syamal Roy Research Topics

Disease

32	Visceral Leishmaniasis (Kala Azar) 01/2022 - 06/2005
32	Infections 01/2022 - 12/2002
14	Leishmaniasis 06/2021 - 09/2004
3	Neoplasms (Cancer) 01/2015 - 03/2008
2	COVID-19 10/2021 - 01/2021
2	Granuloma 12/2012 - 01/2012
1	Sepsis (Septicemia) 09/2022
1	Glaucoma 01/2022
1	Coinfection 01/2022
1	Cataract (Cataracts) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Parasitemia 06/2021
1	Diabetes Mellitus 01/2020
1	Parasitic Diseases (Parasitic Disease) 01/2017
1	Poisoning 01/2017
1	Nocturnal Enuresis (Bedwetting) 10/2014
1	Necrosis 12/2013
1	Hyperlipidemias (Hyperlipidemia) 12/2012
1	Hypercholesterolemia 12/2012
1	Disease Progression 03/2011

Drug/Important Bio-Agent (IBA)

17	AntimonyIBA 01/2022 - 06/2005
10	CytokinesIBA 01/2022 - 09/2004
7	Interleukin-10 (Interleukin 10)IBA 01/2021 - 12/2007
7	VaccinesIBA 06/2016 - 06/2005
6	CholesterolIBA 04/2016 - 06/2009
5	SodiumIBA 06/2021 - 05/2006
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2005
4	AntigensIBA 06/2021 - 10/2005
4	Interleukin-12 (IL 12)IBA 09/2015 - 02/2009
4	gluconic acid (gluconate)FDA LinkGeneric 03/2015 - 05/2006
3	Imipramine (Janimine)FDA LinkGeneric 01/2020 - 01/2012
3	miltefosine (Impavido)IBA 01/2017 - 02/2013
3	Genetic Markers (Genetic Marker)IBA 12/2016 - 09/2012
3	Membrane Proteins (Integral Membrane Proteins)IBA 04/2016 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 10/2014 - 05/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2013 - 11/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 11/2008
3	Interleukin-4 (Interleukin 4)IBA 06/2009 - 06/2005
2	glucogallinIBA 09/2022 - 01/2022
2	Free RadicalsIBA 01/2022 - 01/2012
2	AntioxidantsIBA 01/2022 - 11/2006
2	Liposomes (Liposome)IBA 01/2020 - 06/2009
2	A-Form DNA (A-DNA)IBA 01/2020 - 04/2014
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2015 - 06/2005
2	PhalloidineIBA 12/2014 - 06/2014
2	NitritesIBA 12/2013 - 01/2012
2	LipidsIBA 12/2012 - 04/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2012 - 12/2005
2	EnzymesIBA 07/2012 - 11/2006
2	Interferon-gamma (Interferon, gamma)IBA 09/2011 - 06/2009
2	ChemokinesIBA 12/2005 - 09/2004
1	Sulfhydryl Compounds (Thiols)IBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2020
1	ELAV-Like Protein 1IBA 01/2020
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2020
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2020
1	SqualeneIBA 01/2020
1	voacamineIBA 01/2017
1	rho-Associated KinasesIBA 01/2017
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2017
1	TriterpenesIBA 03/2015
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 03/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015
1	p38 Mitogen-Activated Protein KinasesIBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2015
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Attenuated VaccinesIBA 01/2015
1	Actins (F Actin)IBA 12/2014
1	MetalloidsIBA 10/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2014
1	Peptides (Polypeptides)IBA 06/2014
1	DNA VaccinesIBA 04/2014
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2014
1	Hemoglobins (Hemoglobin)IBA 09/2013
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 02/2013
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2012
1	ApolipoproteinsIBA 12/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2012
1	niranthinIBA 10/2012
1	InterleukinsIBA 07/2012
1	UbiquitinIBA 07/2012
1	Superoxides (Superoxide)IBA 01/2012
1	Concanavalin AIBA 03/2011
1	ChromatinIBA 01/2011
1	Vanadium CompoundsIBA 01/2011
1	lipoarabinomannan (LAM)IBA 01/2011
1	Nitric Oxide Synthase (NO Synthase)IBA 06/2009
1	diperoxovanadateIBA 06/2009
1	ginsenoside M1IBA 06/2009
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2009

Therapy/Procedure

6	Therapeutics 10/2021 - 04/2009
1	Aftercare (After-Treatment) 01/2020